• Users Online:531
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2013  |  Volume : 7  |  Issue : 1  |  Page : 9-21

A multi-centric double-blind randomized homoeopathic pathogenetic trial of Gymnema sylvestre

Goutam Rakshit1, JP Singh2, SD Pathak2, Ch Kishan Banoth3, PK Chandra4, Rajpal5, Sujata Kumari Choudhury1, Vinay Kr Singh1
1 Drug Proving Unit, Extension Unit of RRI (H), Puri, Homoeopathic Medical College and Hospital, Bhubaneswar, Odisha, India
2 Homoeopathic Drug Research Institute, Lucknow, Uttar Pradesh, India
3 Regional Research Institute (H), Gudivada, Andhra Pradesh, India
4 Drug Proving Research Unit, Kolkata, West Bengal, India
5 Central Council for Research in Homoeopathy, New Delhi, India

Correspondence Address:
Goutam Rakshit
Drug Proving Unit, Extension Unit of RRI (H), Puri, Dr. Abhin Chandra Homoeopathic Medical College and Hospital, Unit III, Kharvel Nagar, Bhubaneswar - 751 001, Odisha
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-7168.114270

Rights and Permissions

Objective: To elicit the pathogenetic response of Gymnema sylvestre in homoeopathic potencies on apparently healthy human volunteers. Methodology: Gymnema sylvestre was proved by the Central Council for Research in Homoeopathy through double-blind placebo-controlled method. The study was carried out at four centers. The drug was proved in two potencies (6C and 30C) on 63 apparently healthy volunteers who were selected after conducting pre-trial medical examination by the medical specialists and routine laboratory investigations. In the first phase volunteers were given 56 doses (04 doses per day for 14 days) of placebo. In the next two phases 56 doses (04 doses per day for 14 days) of each potency or placebo were consumed. The symptoms generated during the trial period were noted by the volunteers and elaborated by the proving masters. The data obtained from all the four centers was compiled at proving-cum-data processing cell at CCRH headquarters after decoding. Results: Out of 37 provers who were on actual drug trial, 16 manifested symptoms. The drug was able to produce symptoms in each potency in most of the parts of the body. Conclusion: The pathogenetic responses elicited during the drug proving trial expand the scope of use of the drug Gymnema sylvestre and will benefit the research scholars and clinicians. The generated symptoms of the drug will carry more meaning when verified clinically.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed9909    
    Printed243    
    Emailed0    
    PDF Downloaded892    
    Comments [Add]    
    Cited by others 2    

Recommend this journal

 

Sitemap | What's New | Feedback | Disclaimer
© Indian Journal of Research in Homoeopathy | Published by Wolters Kluwer - Medknow
Online since 05 July, 2013